- Satraplatin and Prednisone to Treat
- Docetaxel plus Prednisone or
- Prednisone and Prostatitis - Reviews -
- FDA Approval for Abiraterone Acetate -
Satraplatin and Prednisone to Treat
Full prescribing information is available, including clinical trial information, safety, dosing, drug-drug interactions and contraindications.
Docetaxel plus Prednisone or
Approved for use with prednisone for metastatic castration-resistant prostate cancer before chemotherapy On December 10, 2012, the Food and Drug Administration (FDA) approved an expanded indication for abiraterone acetate (Zyta tablets, made by Janssen Biotech, Inc.) in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.
Prednisone and Prostatitis - Reviews -
Background: Atrial fibrillation (AF) and atrial flutter (AFL) are common following cardiac surgery and are associated with snificant morbidity.
FDA Approval for Abiraterone Acetate -
Rating: 100 / 100
Overall: 98 Rates